Yesterday, Oct. 14, 2015, 24 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $33.44 to $3,625,890.00.

Highlighted Stocks Traded by Insiders:

Vical (VICL) - FREE Research Report

Samant Vijay B, who is President & CEO at Vical, sold 4,738 shares at $0.41 on Oct. 14, 2015. Following this transaction, the President & CEO owned 1.1 million shares meaning that the stake was reduced by 0.41% with the 4,738-share transaction.

Smith Lawrence Russell, who is VP, Vaccine Research at Vical, sold 974 shares at $0.43 on Oct. 14, 2015. Following this transaction, the VP, Vaccine Research owned 242,055 shares meaning that the stake was reduced by 0.4% with the 974-share transaction.

The shares most recently traded at $0.40, down $0.03, or 6.5% since the insider transaction. Historical insider transactions for Vical go as follows:

  • 4-Week # shares bought: 564,494
  • 4-Week # shares sold: 194
  • 12-Week # shares bought: 564,494
  • 12-Week # shares sold: 194
  • 24-Week # shares bought: 564,494
  • 24-Week # shares sold: 7,163

The average volume for Vical has been 236,900 shares per day over the past 30 days. Vical has a market cap of $36.1 million and is part of the health care sector and drugs industry. Shares are down 62.72% year-to-date as of the close of trading on Wednesday.

Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Currently, there is 1 analyst who rates Vical a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VICL - FREE

TheStreet Quant Ratings

rates Vical as a

sell

. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

Vical Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Turtle Beach (HEAR) - FREE Research Report

Bonanno Carmine J, who is 10% Owner at Turtle Beach, sold 96,300 shares at $3.02 on Oct. 14, 2015. Following this transaction, the 10% Owner owned 5.4 million shares meaning that the stake was reduced by 1.74% with the 96,300-share transaction.

The shares most recently traded at $3.00, down $0.02, or 0.67% since the insider transaction. Historical insider transactions for Turtle Beach go as follows:

  • 4-Week # shares bought: 46,500
  • 4-Week # shares sold: 77,200
  • 12-Week # shares bought: 46,500
  • 12-Week # shares sold: 77,200
  • 24-Week # shares bought: 46,500
  • 24-Week # shares sold: 99,200

The average volume for Turtle Beach has been 218,300 shares per day over the past 30 days. Turtle Beach has a market cap of $117.5 million and is part of the technology sector and telecommunications industry. Shares are down 6.9% year-to-date as of the close of trading on Wednesday.

Turtle Beach Corporation, an audio technology company, develops, commercializes, and markets audio technologies under the Turtle Beach and HyperSound brands in the United States, the United Kingdom, Europe, and internationally. Currently, there are 5 analysts who rate Turtle Beach a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HEAR - FREE

TheStreet Quant Ratings

rates Turtle Beach as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

Turtle Beach Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

comScore (SCOR) - FREE Research Report

Brown Michael Andrew, who is Chief Technology Officer at comScore, sold 400 shares at $50.75 on Oct. 14, 2015. Following this transaction, the Chief Technology Officer owned 24,435 shares meaning that the stake was reduced by 1.61% with the 400-share transaction.

The shares most recently traded at $46.90, down $3.85, or 8.21% since the insider transaction. Historical insider transactions for comScore go as follows:

  • 4-Week # shares sold: 5,600
  • 12-Week # shares sold: 113,639
  • 24-Week # shares sold: 226,618

The average volume for comScore has been 439,200 shares per day over the past 30 days. comScore has a market cap of $1.9 billion and is part of the services sector and diversified services industry. Shares are up 0.75% year-to-date as of the close of trading on Wednesday.

comScore, Inc. provides digital media analytics products and services for content publishers, advertisers, advertising agencies, and network operators primarily in the United States, Canada, Europe, Latin America, and Asia. Currently, there are 5 analysts who rate comScore a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SCOR - FREE

TheStreet Quant Ratings

rates comScore as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full

comScore Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.